PerkinElmer
check quantity

GLP-1 (7-36) (human) LANCE Ultra TR-FRET Detection Kit, 500 Assay Points

The LANCE® Ultra Human GLP-1 (7-36) Detection Kit is designed for detection and quantitation of human GLP-1 (7-36) in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Part Number Unit Size List Price Your Price Quantity
TRF1215C 500 Assay Points 772.00 USD
TRF1215M 10,000 Assay Points 10300.00 USD
Buy Now

You successfully added item(s) to your cart

Overview

The LANCE® Ultra Human GLP-1 (7-36) Detection Kit is designed for detection and quantitation of human GLP-1 (7-36) in cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

  • No-wash steps, no separation steps
  • TR-FRET technology
  • Sensitive detection
  • High reproducibility
  • Faster time-to-results
  • Easy automation
  • 96-well, 384-well, and 1536-well formats

 

LANCE® and LANCE® (Lanthanide chelate excite) Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore (ULight™ dye). Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm.

 

The Glucagon-Like Peptide-1 (GLP-1 (7-36 amide)) is a 30-31 oligopeptide, generated from proglucagon, secreted by the enteroendocrine L cells of the small and large intestine, in a nutrient-dependent manner (some GLP-1 (7-36 amide) is also produced by the pancreatic α-cells and in the central nervous system). Circulating GLP-1 (7-36 amide) levels rapidly increase shortly after ingestion, playing a significant role in the inhibition of gastric emptying and food intake. It is also important for blood glucose homeostasis through the stimulation of insulin biosynthesis and secretion, islet proliferation, and the inhibition of glucagon secretion. Moreover, it regulates hypothalamic-pituitary function and GLP-1 activated circuits mediate the central nervous system response to aversive stimulation. In the circulation, the active form of GLP-1 (GLP-1 (7-36 amide)) is promptly inactivated by the dipeptidyl peptidase IV (DP IV).

Disclaimer:  For research use only. Not for use in diagnostic procedures.

Specifications

Assay Target GLP-1
Assay Target Class Peptide
Automation Compatible Yes
Detection Method Time-Resolved Fluorescence (TRF), TR-FRET
Experimental Type In vitro
Product Brand Name LANCE Ultra
Shipping Condition Blue Ice
Target Species Human
Therapeutic Area Metabolic
Unit Size 500 Assay Points

Resources, Events & More

Resource Type File Name File Format
Brochure LANCE product listing PDF  77 KB
Application Note Quantifying Bcl-2 Expression Levels in Human Cells with LANCE Ultra TR-FRET PDF  3 MB
Manual LANCE Ultra Human GLP-1 (7-36) Detection Kit TRF1215 PDF  504 KB
Flyer LANCE Ultra Biomarker Detection Kits PDF  585 KB